Magnus Medical

medical devices

About

Magnus Medical, Inc. is a privately held medical device company based in Burlingame, California. Co-founded by Brett Wingeier, Ph.D., and Brandon Bentzley, M.D., Ph.D., the company focuses on developing advanced brain stimulation technology for neuropsychiatric disorders, particularly major depressive disorder (MDD). The flagship product, the SAINT® Neuromodulation System, offers a non-invasive therapy that utilizes targeted electromagnetic pulses to alleviate symptoms of treatment-resistant depression (TRD). This innovative system employs MRI-guided algorithms to identify optimal brain targets for precise stimulation, enabling rapid symptom relief, often within five days. The SAINT system received Breakthrough Device Designation and 510(k) clearance from the FDA in September 2022, marking a significant advancement in treatment options for adults with MDD who have not responded to previous medications. Magnus Medical is committed to expanding access to this therapy across various healthcare facilities in the U.S.

Technologies

Route 53 Gmail Google Apps Amazon AWS Google Tag Manager Mobile Friendly IoT Remote AI

Keywords

mental health & brain health medical equipment manufacturing brain connectivity restoration targeted brain stimulation brain circuit modulation tms safety profile mri-guided targeting personalized neuromodulation brain network activity tms protocol treatment-resistant depression brain circuitry modification stanford licensed technology non-invasive treatment brain network modulation mental health treatment magnetic stimulation brain stimulation system b2b brain network targeting clinical trial results brain health tms clinical research tms for depression accelerated therapy accelerated neuromodulation personalized therapy healthcare equipment & supplies personalized brain therapy services

Location

1350 Old Bayshore Highway, Burlingame, California, United States, 94010

Related Companies

Companies in the same industry